Subject(s)
Betacoronavirus , Coronavirus Infections/diagnostic imaging , Locked-In Syndrome/diagnostic imaging , Pneumonia, Viral/diagnostic imaging , Polyradiculoneuropathy/diagnostic imaging , Acute Disease , COVID-19 , Coronavirus Infections/complications , Coronavirus Infections/drug therapy , Humans , Immunoglobulins, Intravenous/administration & dosage , Locked-In Syndrome/complications , Locked-In Syndrome/drug therapy , Male , Middle Aged , Pandemics , Pneumonia, Viral/complications , Pneumonia, Viral/drug therapy , Polyradiculoneuropathy/complications , Polyradiculoneuropathy/drug therapy , SARS-CoV-2ABSTRACT
A 9-year-old girl was severely injured in a car accident in Afghanistan, in which both her lower legs were badly damaged. She was treated at the Hospital of Ingolstadt (Klinikum Ingolstadt) after she had undergone initial surgery at an Indian hospital. Various bacterial species were isolated from multiple wounds, and methicillin-resistant Staphylococcus aureus (MRSA) was one among them. After the amputation of her lower legs, she developed MRSA sepsis, which was successfully treated with a relatively low dosage of ceftaroline (Zinforo(®)/Teflaro(®); 2×9 mg/kg/d), although the bacterial isolate's minimal inhibitory concentration (1.5-4 mg/L) suggested a decreased susceptibility. In summary, ceftaroline was highly efficient and well tolerated by the patient suffering from MRSA sepsis.
